Immunomodulatory & Targeted Therapies for Glomerular Diseases
Gain insights into targeted biological agents and immunosuppressants tailored for treating glomerular disorders like FSGS and minimal change disease. Learn how personalized immunotherapy is revolutionizing glomerular disease management. Explore advances in monoclonal antibodies, complement inhibitors, and T-cell modulating therapies designed to minimize relapse and preserve renal function. Understand the role of biomarkers in predicting therapeutic response and guiding individualized treatment plans. Delve into clinical trial outcomes evaluating the safety and efficacy of emerging immunomodulators. Discuss strategies for balancing immune suppression with infection risk in long-term disease management.